Biologics in systemic lupus erythematosus: current options and future perspectives

被引：6
|
作者：
Yusof, Yuzaiful Md [1 ,2 ]
Vital, Edward M. [1 ,2 ]
Emery, Paul [1 ,2 ]
机构：
[1] Univ Leeds, Chapel Allerton Hosp, Leeds Inst Rheumat & Musculoskeletal Med, Leeds LS7 4SA, W Yorkshire, England
[2] Leeds Teaching Hosp NHS Trust, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 2014年 / 75卷 / 08期
关键词：
B-LYMPHOCYTE STIMULATOR; DOUBLE-BLIND; DISEASE-ACTIVITY; PHASE-III; EFFICACY; SAFETY; NEPHRITIS; RITUXIMAB; BELIMUMAB; MANIFESTATIONS;
D O I：
10.12968/hmed.2014.75.8.440
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：440 / 447
页数：8
相关论文
共 50 条
  • [31] New developments in the treatment of systemic lupus erythematosus
    Tullus, Kjell
    PEDIATRIC NEPHROLOGY, 2012, 27 (05) : 727 - 732
  • [32] Subcutaneous belimumab in the treatment of systemic lupus erythematosus
    Elalouf, Ofir
    Keeling, Stephanie O.
    Touma, Zahi
    IMMUNOTHERAPY, 2018, 10 (13) : 1163 - 1173
  • [33] Research on biological therapies in systemic lupus erythematosus
    Cervera, Ricard
    MEDICINA CLINICA, 2017, 148 (02): : 67 - 68
  • [34] The safety of belimumab for the treatment of systemic lupus erythematosus
    Wise, Leanna M.
    Stohl, William
    EXPERT OPINION ON DRUG SAFETY, 2019, 18 (12) : 1133 - 1144
  • [35] Upcoming biological therapies in systemic lupus erythematosus
    Sciascia, Savino
    Talavera-Garcia, Eva
    Roccatello, Dario
    Baldovino, Simone
    Mengatti, Elisa
    Cuadrado, Maria Jose
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 27 (02) : 189 - 193
  • [36] Systemic lupus erythematosus 2020
    Narvaez, Javier
    MEDICINA CLINICA, 2020, 155 (11): : 494 - 501
  • [37] Belimumab for systemic lupus erythematosus
    Singh, Jasvinder A.
    Shah, Nipam P.
    Mudano, Amy S.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (02):
  • [38] Systemic lupus erythematosus: an update on current pharmacotherapy and future directions
    Touma, Zahi
    Urowitz, Murray B.
    Gladman, Dafna D.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (05) : 723 - 737
  • [39] Anifrolumab in systemic lupus erythematosus: current knowledge and future considerations
    Anderson, Erik
    Furie, Richard
    IMMUNOTHERAPY, 2020, 12 (05) : 275 - 286
  • [40] Targeting Interferons in Systemic Lupus Erythematosus: Current and Future Prospects
    Mathian, Alexis
    Hie, Miguel
    Cohen-Aubart, Fleur
    Amoura, Zahir
    DRUGS, 2015, 75 (08) : 835 - 846
12345